Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Account Payables: 2022-2023

Historic Change in Account Payables for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $394,000.

  • Lexeo Therapeutics' Change in Account Payables rose 132.27% to $394,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$180,000, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is 1421.11% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' Change in Account Payables is $394,000, which was up 35.86% from $290,000 recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Change in Account Payables high stood at $1.0 million for Q1 2023, and its period low was -$1.9 million during Q2 2023.
  • Over the past 2 years, Lexeo Therapeutics' median Change in Account Payables value was $290,000 (recorded in 2023), while the average stood at -$280,200.
  • Data for Lexeo Therapeutics' Change in Account Payables shows a peak YoY surged of 132.27% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Lexeo Therapeutics' Change in Account Payables stood at -$1.2 million in 2022, then surged by 132.27% to $394,000 in 2023.
  • Its Change in Account Payables stands at $394,000 for Q4 2023, versus $290,000 for Q3 2023 and -$1.9 million for Q2 2023.